glp-1 hfpef receptor agonists, including semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound), are being recognized for benefits beyond blood sugar control and weight management. New real-world evidence suggests they may also play a role in Efficacy of GLP‐1 receptor agonists

GLP-1 medications are typically administered via injection and work by binding to GLP-1 receptors in the body

Al-Kuraishy HM, Al-Gareeb AI, Alexiou A et al (2022a) 5-HT/CGRP pathway and Sumatriptan role in Covid-19

Whats actually happening inside her body is a different story. In This Article What a GLP-1 actually does to a perimenopausal body including the muscle loss the scale doesnt show The four pillars of proper support: protein, training, testing, and repletion The specific lab panel and body composition tests worth doing on a GLP-1 How to come off the medication without rebounding and why preparation starts now, not later Why GLP-1s and Perimenopause Need Their Own Conversation Perimenopause is already a metabolic and hormonal transition unlike anything your body has navigated before

However, such intervention is highly invasive, has considerable risk and is irreversible and expensive

Side effect profiles are largely similar between oral and injectable semaglutide, with fewer than 10% of patients discontinuing due to adverse effects

The bottom line Ozempic has helped a growing number of people manage their diabetes and shed some excess weight, which also helps with their diabetes management